ArticleBMJ open2023

Protocol for a multicentre, double-blind, randomised, placebo-controlled trial of riociguat on peak cardiac index during exercise in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty (THERAPY-HYBRID-BPA trial).

Hiroto Shimokawahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.